VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. (Q39860463)
Jump to navigation
Jump to search
scientific article published on 16 April 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. |
scientific article published on 16 April 2009 |
Statements
VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1 (English)
P Schache
E Gürlevik
N Strüver
N Malek
L Zender
M Manns
T Wirth
F Kühnel
1 reference